ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.787,08
0,06%
S&P 500
5.509,01
0,62%
US Dollar vs BRL
5,6766
-0,01%
Bitcoin
60.519,52
-2,43%
Brent Oil
86,26
-0,21%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aptevo Therapeutics Inc (APVO)

  7. Aptevo Therapeutics Inc (APVO) Notícias

APVO

Aptevo Therapeutics (APVO)

Aptevo Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:APVO
DataHoraFonteTítuloCódigoCompanhia
14/06/202417:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
10/06/202417:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
03/06/202417:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
08/05/202409:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
05/03/202410:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APVOAptevo Therapeutics Inc
30/01/202410:00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
22/12/202318:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
12/12/202318:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
01/12/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
22/11/202318:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
03/08/202318:21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APVOAptevo Therapeutics Inc
01/08/202317:01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APVOAptevo Therapeutics Inc
02/06/202317:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APVOAptevo Therapeutics Inc
02/06/202317:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APVOAptevo Therapeutics Inc
19/04/202309:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:APVOAptevo Therapeutics Inc
18/04/202309:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APVOAptevo Therapeutics Inc
30/03/202309:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APVOAptevo Therapeutics Inc
07/03/202318:44Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APVOAptevo Therapeutics Inc
07/03/202318:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APVOAptevo Therapeutics Inc
14/02/202312:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APVOAptevo Therapeutics Inc
12/12/202212:33TipRanksAptevo Skyrockets on Promising Clinical DataNASDAQ:APVOAptevo Therapeutics Inc
10/11/202210:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APVOAptevo Therapeutics Inc
30/03/202209:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:APVOAptevo Therapeutics Inc
29/03/202208:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APVOAptevo Therapeutics Inc
22/11/202119:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APVOAptevo Therapeutics Inc
02/11/202110:00GlobeNewswire Inc.BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of DirectorsNASDAQ:APVOAptevo Therapeutics Inc
20/08/202107:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APVOAptevo Therapeutics Inc
11/05/202109:56Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:APVOAptevo Therapeutics Inc
28/04/202117:21Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)NASDAQ:APVOAptevo Therapeutics Inc
28/04/202117:19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APVOAptevo Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:APVO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
OIBR3
OI ON
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados